Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation
Status:
Completed
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if Apixaban will decrease the complication of having
another stroke for people who have atrial fibrillation if initiated earlier than standard of
care.